GGrantIndex
← Leaderboards

Frederic G Barr

University Of Pennsylvania

$8,847,995
Attributed
$8,847,995
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.5M · FY200510
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10

Funding mix

By agency

NIH$8,847,995 · 6

By mechanism

R01$6,603,163 · 4
R25$2,070,832 · 1
R21$174,000 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Neoplasm /Cancer Genetics

Research focus

Neoplasm /Cancer GeneticsRhabdomyosarcomaTranscription FactorPolymerase Chain ReactionChromosome TranslocationClinical ResearchFusion GeneHuman SubjectMolecular OncologySouthern BlottingGene ExpressionTissue /Cell CultureOncogenesPhenotypeFluorescent In Situ HybridizationTumorBaseCell LineNeoplasm /Cancer EducationGenesEducation Evaluation /Planning12q13BehaviorAlveolar

Grant awards (28)

DNA methylation-based assays for detecting disease spread in rhabdomyosarcoma$174,000
R21 · FY2010 · CA · contact PI
COG studies of gene amplification in rhabdomyosarcoma$129,973
R01 · FY2009 · CA · contact PI
COG studies of gene amplification in rhabdomyosarcoma$417,146
R01 · FY2008 · CA · contact PI
COG studies of gene amplification in rhabdomyosarcoma$413,715
R01 · FY2007 · CA · contact PI
Studies of the t(2;13) of alveolar rhabdomyosarcoma$338,145
R01 · FY2007 · CA · contact PI
COG studies of gene amplification in rhabdomyosarcoma$414,385
R01 · FY2006 · CA · contact PI
Studies of the t(2;13) of alveolar rhabdomyosarcoma$348,245
R01 · FY2006 · CA · contact PI
Cancer Molecular Pathology Training Program$174,805
R25 · FY2006 · CA · contact PI
Cancer Molecular Pathology Training Program$493,481
R25 · FY2005 · CA
COG studies of gene amplification in rhabdomyosarcoma$433,451
R01 · FY2005 · CA
Studies of the t(2;13) of alveolar rhabdomyosarcoma$356,625
R01 · FY2005 · CA
IRSG STUDIES OF ALVEOLAR RHABDOMYOSARCOMA GENE FUSIONS$237,820
R01 · FY2005 · CA
Cancer Molecular Pathology Training Program$615,932
R25 · FY2004 · CA
Studies of the t(2;13) of alveolar rhabdomyosarcoma$356,625
R01 · FY2004 · CA
IRSG STUDIES OF ALVEOLAR RHABDOMYOSARCOMA GENE FUSIONS$240,645
R01 · FY2004 · CA
Studies of the t(2;13) of alveolar rhabdomyosarcoma$356,625
R01 · FY2003 · CA
IRSG STUDIES OF ALVEOLAR RHABDOMYOSARCOMA GENE FUSIONS$243,389
R01 · FY2003 · CA
Cancer Molecular Pathology Training Program$220,591
R25 · FY2003 · CA
Cancer Molecular Pathology Training Program$361,903
R25 · FY2002 · CA
STUDIES OF THE T (2;13) OF ALVEOLAR RHABDOMYOSARCOMA$361,500
R01 · FY2002 · CA
IRSG STUDIES OF ALVEOLAR RHABDOMYOSARCOMA GENE FUSIONS$249,774
R01 · FY2002 · CA
STUDIES OF THE T (2;13) OF ALVEOLAR RHABDOMYOSARCOMA$307,151
R01 · FY2001 · CA
IRSG STUDIES OF ALVEOLAR RHABDOMYOSARCOMA GENE FUSIONS$289,326
R01 · FY2001 · CA
REGULATION OF PAX3/PAX7 EXPRESSION IN RHABDOMYOSARCOMA$240,546
R01 · FY2001 · CA
Cancer Molecular Pathology Training Program$204,120
R25 · FY2001 · CA
STUDIES OF THE T (2;13) OF ALVEOLAR RHABDOMYOSARCOMA$190,200
R01 · FY2001 · CA
STUDIES OF THE (2;13) OF ALVEOLAR RHABDOMYOSARCOMA$443,198
R01 · FY2000 · CA
REGULATION OF PAX3/PAX7 EXPRESSION IN RHABDOMYOSARCOMA$234,679
R01 · FY2000 · CA